Volcanics Venture

Volcanics Venture is a venture capital firm established in May 2016, headquartered in Shanghai, China, with an additional office in Beijing. The firm focuses on investing in start-up, early, and growth stages of companies within technology-driven sectors, including internet innovation, intelligent technology, and healthcare. It emphasizes advanced fields such as artificial intelligence, genomics, proteomics, microbiology, and cloud technology. The managing partners, Suyang Zhang, Yeshun Dong, and Ying Wu, bring over 60 years of combined experience in venture capital investment and corporate management. Volcanics Venture aims to identify and support promising entrepreneurs, providing valuable insights and services to enhance the growth of its portfolio companies while delivering superior returns to its investors.

Yeshun Dong

Managing Partner

Alicia Han

CFO

Siyu Miao

Senior Associate

Chenhui Wang

Managing Director

Young Yang

Vice President

Zhoubo Ye

Vice President

Suyang Zhang

Managing Partner

81 past transactions

Aiagain

Series B in 2022
Provider of online WeChat management platform for WeChat sellers. The platform creates a system that includes customer acquisition, engagement, and retention, enabling enterprises to more efficiently manage their sales forces in utilizing WeChat as a tool.

Fabrie

Seed Round in 2022
Fabrie develops collaboration tool for designers that has functions such as multi-person collaboration, table and diagram association, cloud storage and sharing.

FlowUs

Angel Round in 2022
Provider of a productivity software. The company provides a productivity tool that integrates documents, tables, folders as well as instant collaboration in the cloud, enabling an one-stop platform formalizing information organization and efficiency for individuals and teams.

Ideamake

Series C in 2022
Ideamake is a VR viewing solution provider that builds a virtual house environment through virtual reality technology. The house scene is composed of digital models of real data, follows engineering design standards and requirements, and reproduces the planned project. To help users choose the decoration style that suits them.

BOOLV

Series A in 2022
BOOLV is a software-as-a-service (SaaS) provider specializing in AI-driven video generation. The company focuses on creating automatic short marketing videos, primarily catering to e-commerce clients in sectors such as fashion and furniture. By utilizing big data and artificial intelligence, BOOLV generates engaging video clips designed for marketing purposes. The company has established successful collaborations with a variety of well-known brands across different industries, including academia. BOOLV aims to deliver comprehensive video marketing solutions that enhance the online presence and promotional efforts of its clients.

Enze Kangtai

Series A in 2022
Echo Biotech is a biotech firm mainly engaged in the R&D and production of exosome molecular diagnostic products and exosome research.

Yunli Smart Technology

Series A in 2021
Yunli Zhihui Technology(Cloud Wisdom Technology) is a venture capital firm.

Alluxio

Series C in 2021
Alluxio, Inc. (formerly Tachyon Nexus) team consists of the creators and top committers of Alluxio (formerly Tachyon), an open source project from UC Berkeley AMPLab. For the past three years, we have been working to revolutionize the way data is stored, accessed, and managed by focusing on a memory-centric architecture. We believe this new approach is key to delivering the next generation storage.

Thinktech

Series A in 2021
Developer of security systems and related chips intended to serve the automobile industry. The company's main business covers the design and development of automotive semiconductor chips and product applications. It focuses on the intelligent networked automotive industry, providing Internet of vehicles (IoV) enterprises with semiconductor chip products and solutions.

Space Transportation

Venture Round in 2021
Space Transportation designs and manufactures space transport systems intended to reduce space exploration costs. It specializes in developing reusable commercial space transport vehicles, aiming to reduce commercial launch costs associated with reentry and carrier recycling.

Huleen

Angel Round in 2021
Huleen is committed to opening up application boundaries and bringing together more information.

Dynasty Gene

Series A in 2021
Shanghai Dynasty Gene Technology Co., Ltd. is a biotechnology company based in Shanghai, China, specializing in the research and development of synthetic blood testing products and reagents. Founded in 2018, the company offers a range of products, including liquid phase capture probe products like the DEMATCH ctDNA NCCN Kit and the DEMATCH ctDNA Pan Cancer Kit, as well as multiplex PCR primers, next-generation sequencing (NGS) kits, and associated instruments and software. Dynasty Gene also provides biotechnology consulting services, focusing on technology development, transfer, and technical support to help clients advance in the NGS field. The company possesses independent intellectual property rights to its Micropore high-throughput DNA synthesis platform, which enables the launch of innovative products, including liquid biopsy solutions and NGS library capture kits.

Zenlayer

Series C in 2021
Zenlayer operates as a software-defined network and services provider. It offers bare metal cloud, SD-WAN cloud connect, edge computing, and colocation in over 100 data centers on six continents. Enterprises utilizes Zenlayer’s SDx platforms to instantly enable worldwide connectivity and deliver the user experience. The company was founded in 2014 and is headquartered in Diamond Bar, California.

Phanes Therapeutics

Series B in 2021
Phanes Therapeutics, Inc. is a biotechnology company based in San Diego, California, established in 2016. It specializes in the discovery and development of therapeutics aimed at treating solid tumors and eye diseases. The company's portfolio includes a monoclonal antibody designed for solid tumors and various ophthalmic conditions such as age-related macular degeneration, diabetic macular edema, and diabetic retinopathy. Additionally, Phanes Therapeutics is developing a bispecific antibody targeting small cell lung cancer. With a focus on scientific innovation, the company strives to create advanced therapeutic options that enhance patient care and improve lives worldwide.

Alpha Cen

Seed Round in 2021
Alpha Cen is a developer of wafer-level metasurface light control chips and modules. It offers a semiconductor IC-compatible process to integrate micro-nano optical metasurfaces with circuits, light sources, and photodetectors.

Hexcloud

Series A in 2020
Shanghai Hexcloud Information CO.,Ltd. engages in developing business/front-end product and operational online solutions for the retail chain industry. The services provided by the company provide benefits, such as chain brand digital management, professional teams, industry business data, and native cloud computing technology. The company is based in Shanghai, China.

Vision Medicals

Series B in 2020
Guangzhou Vision Medicals Technology Co., Ltd. specializes in genetic technology and precision medicine, particularly in the realm of pathogen diagnostics. The company develops a range of products aimed at tumor-targeted drug detection, early screening, and accurate identification of pathogens, along with drug resistance genes and virulence factors. Vision Medicals employs advanced technologies, including high-throughput sequencing and CRISPR-based rapid diagnostics, to enhance clinical pathogen detection and reduce reporting times. Additionally, it has created a pathogenic nucleic acid enrichment technology, which has gained recognition for its effectiveness in detecting pathogenic micronucleic acids in clinical samples. By leveraging big data in pathogen detection and employing intelligent genomic analysis, the company significantly contributes to the infection-precise medical industry. Based in Guangzhou, China, Vision Medicals primarily serves pediatric departments in tertiary hospitals.

Brite Semiconductor

Series D in 2020
Brite Semiconductor, Inc., founded in 2008 and headquartered in Shanghai, China, specializes in system-on-chip (SoC) and application-specific integrated circuit (ASIC) design and manufacturing services. The company offers a comprehensive range of services, including supply chain and production management, manufacturing engineering, and quality assurance, which encompasses wafer fabrication, assembly, packaging, and testing. Brite's YouIP portfolio includes various branches that provide silicon-proven intellectual property to facilitate product development from specification to silicon, ensuring a higher delivery rate and reduced time to market. With a commitment to leveraging advanced technology and competitive pricing, Brite Semiconductor employs an Open Model to deliver flexible and cost-effective designs tailored to customer needs. The company's unique MAX technology enhances yield while minimizing costs, making it a preferred partner for advanced semiconductor designs. Brite Semiconductor has established a proven track record with over 200 successful tapeouts, positioning itself as a reliable choice for clients seeking comprehensive ASIC solutions.

Cloudpick

Series A in 2020
Yuna Technology is a high-tech enterprise specializing in the development of computer vision and artificial intelligence applications. The company is committed to leading the technological breakthrough of the core knowledge of artificial intelligence, and building an overall application solution for artificial intelligence and big data analysis in multiple industries.

Polaris Biology

Series B in 2020
Shanghai Polaris Biology Co., Ltd. is a medical technology company focused on developing a cell diagnostic technology platform for tumors. Established in 2016 and based in Shanghai, China, the company utilizes artificial intelligence-based cell analysis models to examine dynamic changes in tumors at the cellular level. This innovative approach aims to enhance clinical tumor diagnosis and treatment by providing precise and accurate diagnostic tools for both patients and healthcare professionals. Polaris Biology is dedicated to advancing the understanding of individual tumor characteristics, thereby supporting more effective clinical decision-making in cancer care.

Alluxio

Series B in 2020
Alluxio, Inc. (formerly Tachyon Nexus) team consists of the creators and top committers of Alluxio (formerly Tachyon), an open source project from UC Berkeley AMPLab. For the past three years, we have been working to revolutionize the way data is stored, accessed, and managed by focusing on a memory-centric architecture. We believe this new approach is key to delivering the next generation storage.

Hannto Technology

Series B in 2020
Hannto Technology Inc. develops smart devices and iOT applications. The company offers XPRINT, a mobile photo printer. The company was founded in 2017 and is based in Shanghai, China.

RootPath

Series A in 2020
RootPath Genomics, Inc. is a biotechnology company based in Cambridge, Massachusetts, founded in 2017. The company specializes in developing a personalized T-cell therapy platform that integrates precision medicine with cancer immunotherapy. By focusing on the analysis and manipulation of single immune cells, RootPath aims to enhance the understanding of anti-tumor immunity. Their innovative technologies enable drug developers, physicians, and patients to monitor, modulate, and direct the immune system, facilitating advancements in the diagnosis and treatment of cancer.

Space Transportation

Seed Round in 2019
Space Transportation designs and manufactures space transport systems intended to reduce space exploration costs. It specializes in developing reusable commercial space transport vehicles, aiming to reduce commercial launch costs associated with reentry and carrier recycling.

Caicloud

Series B in 2019
Caicloud is a private cloud computing company founded in July 2015 and headquartered in Hangzhou, China. The company specializes in providing Kubernetes-based Cluster-as-a-Service (CaaS) solutions, with its latest product, CaaS 2.0, enhancing cluster management through improved security, DevOps capabilities, application orchestration, and troubleshooting intelligence. This new version builds upon its initial CaaS offering from December 2015 and is designed to integrate with public clouds and on-premises infrastructures such as VMware and OpenStack. Caicloud serves several Fortune 500 companies by delivering enterprise Kubernetes distributions. Additionally, the company has developed TensorFlow-as-a-Service (TaaS) to create a comprehensive "Cloud + AI" solution for enterprises, offering features like automatic anomaly detection and data-driven troubleshooting. Caicloud is also notable for its contributions to the Kubernetes community, having open-sourced various plugins, tools, and a Kubernetes-native CI/CD project named Cyclone.

Eoitek

Series B in 2019
EOITEK develops and delivers big data analysis solutions. It offers AIOps, a self-developed intelligent operation and maintenance product that collects, processes, analyzes, and displays multi-dimensional full-scale operation and maintenance data, including fault events, performance indicators, various logs, operation and maintenance work orders, and configuration data. The company’s solutions are deployed onsite and are available as a subscription service model. It serves customer in various industries, including banking, insurance, securities, manufacturing, energy, and transportation. The company was founded in 2014 and is based in Shanghai, China.

Naxions

Series B in 2019
Beijing Naxions Technology Co., Ltd. is a healthcare-focused company that specializes in providing digital marketing services tailored for the pharmaceutical industry. Founded in 2014 and headquartered in Chaoyang District, China, with additional offices in Shanghai, Naxions has developed a software-as-a-service (SaaS) platform designed to enhance pharmaceutical sales management. The platform offers a range of services, including data capture, cleaning, and analysis, alongside features for content sharing and project management. By leveraging internet technology, Naxions aims to support pharmaceutical enterprises in developing their brand image and increasing market awareness through real-time data analysis and visualization.

Beijing Gene+ Technology

Series B in 2019
Beijing Gene+ Technology, founded in 2015 and based in Beijing, China, specializes in gene testing services aimed at cancer prevention and early detection. The company provides a range of offerings, including clinical testing, medical device manufacturing, and scientific cooperation services. It plays a significant role in supporting precision medicine by delivering critical data for treatment planning. Beijing Gene+ Technology operates in approximately 100 hospitals and has served thousands of cancer patients across China, contributing to advancements in personalized healthcare solutions.

Ruixun Biotech

Series A in 2019
Suzhou Ruixun Biotechnology Co., Ltd. specializes in the development of medical equipment focused on molecular diagnostics and gene detection. Founded in 2017 and headquartered in Suzhou, China, the company offers a range of products including digital polymerase chain reaction (PCR) systems, genetic diagnosis devices, and associated reagents. Ruixun Biotech aims to advance healthcare through innovative diagnostic solutions.

Vision Medicals

Series A in 2019
Guangzhou Vision Medicals Technology Co., Ltd. specializes in genetic technology and precision medicine, particularly in the realm of pathogen diagnostics. The company develops a range of products aimed at tumor-targeted drug detection, early screening, and accurate identification of pathogens, along with drug resistance genes and virulence factors. Vision Medicals employs advanced technologies, including high-throughput sequencing and CRISPR-based rapid diagnostics, to enhance clinical pathogen detection and reduce reporting times. Additionally, it has created a pathogenic nucleic acid enrichment technology, which has gained recognition for its effectiveness in detecting pathogenic micronucleic acids in clinical samples. By leveraging big data in pathogen detection and employing intelligent genomic analysis, the company significantly contributes to the infection-precise medical industry. Based in Guangzhou, China, Vision Medicals primarily serves pediatric departments in tertiary hospitals.

Furrytail

Series A in 2019
“FURRYTAIL ” believes that enterprise innovation in cut-off categories lacks channel integration advantages, and targeting “crowds” can help shape the cultural consumer group and capture the market. Targeting the youngest cat population with the highest life cycle value , "FURRYTAIL Tail Life" cuts into the "crowd brand" construction, and develops the full life cycle value (LTV) of the cat-specific population from the initial stage around the 90-year-old cat population. Incremental user demand development.

Dynasty Gene

Series A in 2019
Shanghai Dynasty Gene Technology Co., Ltd. is a biotechnology company based in Shanghai, China, specializing in the research and development of synthetic blood testing products and reagents. Founded in 2018, the company offers a range of products, including liquid phase capture probe products like the DEMATCH ctDNA NCCN Kit and the DEMATCH ctDNA Pan Cancer Kit, as well as multiplex PCR primers, next-generation sequencing (NGS) kits, and associated instruments and software. Dynasty Gene also provides biotechnology consulting services, focusing on technology development, transfer, and technical support to help clients advance in the NGS field. The company possesses independent intellectual property rights to its Micropore high-throughput DNA synthesis platform, which enables the launch of innovative products, including liquid biopsy solutions and NGS library capture kits.

Zenlayer

Series B in 2019
Zenlayer operates as a software-defined network and services provider. It offers bare metal cloud, SD-WAN cloud connect, edge computing, and colocation in over 100 data centers on six continents. Enterprises utilizes Zenlayer’s SDx platforms to instantly enable worldwide connectivity and deliver the user experience. The company was founded in 2014 and is headquartered in Diamond Bar, California.

Fourier Intelligence

Series B in 2019
Shanghai Fourier Intelligence Co. Ltd. specializes in the development of exoskeleton and rehabilitation robotics products aimed at enhancing mobility and therapeutic outcomes for users with movement impairments. Key products include the ExoMotus X2, an exoskeleton robot designed for walking assistance, and the ArmMotus M2, which aids in arm rehabilitation, focusing on shoulder and elbow joint movement. The WristMotus M1-W facilitates normal wrist movements, while CycleMotus provides an intuitive interface for patients to continue rehabilitation at home after clinical discharge. Additionally, the company is involved in various initiatives such as the Fourier Intelligence Group Therapy (FiGT), the Fourier Intelligent Rehabilitation Hub (FiRH), and the Fourier Exoskeleton & Robotics Open Platform System (EXOPS), which are aimed at advancing education and development in exoskeleton and robotics systems. Founded in 2015 and based in Shanghai, Fourier Intelligence combines technology and design to address the needs of individuals with disabilities and enhance their quality of life.

AIMON

Series C in 2019
Aimon, based in Shanghai, China, specializes in the design and development of cartoon animations and related derivative products. Founded in 2013, the company creates a variety of items, including toy models, clothing, office stationery, suitcases, and daily consumables. Aimon collaborates with renowned animation brands from Japan and Taiwan, purchasing intellectual property rights from original creators to produce products that cater to anime enthusiasts. Through its focus on cultural and creative derivatives, Aimon aims to deliver unique and engaging products to a diverse audience.

LenoMed Medical

Series C in 2019
LenoMed Medical is a medical equipment manufacturer based in Shanghai, China, established in 2014. The company specializes in the development and production of insulin pumps, drug infusion pumps, and related disposables, including the InnoTech insulin pump and infusion sets. With over 15 years of research and development experience in infusion technology, LenoMed is focused on advancing diabetes management through innovative solutions. The company is exploring the integration of continuous glucose monitoring (CGM) technology with insulin pumps to create a closed-loop system, enhancing diabetes care management. LenoMed has formed a strategic alliance with The Pharma Partners to further its objectives in this sector.

Spacetouch

Series A in 2019
Zhuhai Pulin Core Technology Co., Ltd. was founded by many professors and doctors of electrical engineering at Princeton University. The founding members are rich in human-computer interaction and R&D experience in the field of integrated circuits. The company is committed to human-computer interaction. The world's leading provider of core chips and solutions in the field.

Polaris Biology

Series A in 2019
Shanghai Polaris Biology Co., Ltd. is a medical technology company focused on developing a cell diagnostic technology platform for tumors. Established in 2016 and based in Shanghai, China, the company utilizes artificial intelligence-based cell analysis models to examine dynamic changes in tumors at the cellular level. This innovative approach aims to enhance clinical tumor diagnosis and treatment by providing precise and accurate diagnostic tools for both patients and healthcare professionals. Polaris Biology is dedicated to advancing the understanding of individual tumor characteristics, thereby supporting more effective clinical decision-making in cancer care.

Aiqi Technology

Series B in 2018
Beijing AIQI Technology Co., Ltd. is an Internet technology company founded in 2013 and based in Beijing, China. The company specializes in the research and development of artificial intelligence and robotic technology, focusing on the creation of DIY intelligent robots. AIQI has developed a range of interactive robots aimed at K-12 STEM education, promoting human-machine interaction and creativity among users. In recent years, the company has secured numerous patents in intelligent equipment and established a partnership with the technology giant Xiaomi, becoming the sole provider of DIY intelligent robots within Xiaomi's ecosystem. With a strong research team and advanced production capabilities, AIQI Technology aims to deliver innovative and user-friendly robotic solutions that enhance modern life.

Furrytail

Seed Round in 2018
“FURRYTAIL ” believes that enterprise innovation in cut-off categories lacks channel integration advantages, and targeting “crowds” can help shape the cultural consumer group and capture the market. Targeting the youngest cat population with the highest life cycle value , "FURRYTAIL Tail Life" cuts into the "crowd brand" construction, and develops the full life cycle value (LTV) of the cat-specific population from the initial stage around the 90-year-old cat population. Incremental user demand development.

Geek+

Series B in 2018
Geek+ has delivered the largest numbers of logistics robots among its peers in China. The company's customers include e-commerce platforms, third-party logistics providers, express delivery companies, offline retailers and manufacturers of apparels, pharmaceuticals, automobiles and electronics products. Geek+ has also established strategic partnerships with a number of key customers to co-develop customized AI and robotic solutions across different industries and applications.

Urban Fable

Series A in 2018
Urban Fable Basketball Club (Beijing) Co is a sports company.

GJS Robot

Series B in 2018
GJS Co., Ltd. is a Shenzhen-based company that specializes in the development and manufacturing of personalized fighting robots for one-on-one combat and gaming competitions. Established in 2015, GJS Robot offers products such as Ganker robots, which utilize servo motors and wheels for responsive movement, and GEIO robots, which feature infrared cameras and deep learning technology for environmental and facial recognition. The company's focus on integrating advanced technology into their robots aims to enhance the gaming experience and provide customizable options for clients in the robotics and gaming industries.

RootPath

Seed Round in 2018
RootPath Genomics, Inc. is a biotechnology company based in Cambridge, Massachusetts, founded in 2017. The company specializes in developing a personalized T-cell therapy platform that integrates precision medicine with cancer immunotherapy. By focusing on the analysis and manipulation of single immune cells, RootPath aims to enhance the understanding of anti-tumor immunity. Their innovative technologies enable drug developers, physicians, and patients to monitor, modulate, and direct the immune system, facilitating advancements in the diagnosis and treatment of cancer.

Shebaotong

Series B in 2018
Shebaotong provides social security, provident fund, commercial insurance, salary services, labor cost optimization and other services.

ImageDT

Series A in 2018
Developer of image recognition and semantic analysis technology designed to focus on providing business intelligence for enterprises. The company's technology offers offline inventory, e-commerce monitoring and online public opinion insight, enabling businesses to identify growth opportunities.

Ruixun Biotech

Seed Round in 2018
Suzhou Ruixun Biotechnology Co., Ltd. specializes in the development of medical equipment focused on molecular diagnostics and gene detection. Founded in 2017 and headquartered in Suzhou, China, the company offers a range of products including digital polymerase chain reaction (PCR) systems, genetic diagnosis devices, and associated reagents. Ruixun Biotech aims to advance healthcare through innovative diagnostic solutions.

IPSTAR

Seed Round in 2018
IPSTAR is a Media & Entertainment Start up.

Aiagain

Series A in 2018
Provider of online WeChat management platform for WeChat sellers. The platform creates a system that includes customer acquisition, engagement, and retention, enabling enterprises to more efficiently manage their sales forces in utilizing WeChat as a tool.

OncXerna Therapeutics

Seed Round in 2018
OncXerna Therapeutics offers precision medicine using an innovative RNA-based biomarker platform. OncXerna Therapeutics is aiming to deliver next-generation precision medicine for a larger group of cancer patients by leveraging the company’s deep understanding of how to prospectively identify patients based on the dominant biology of their tumor microenvironments. This allows OncXerna to pair those patients with OncXerna’s clinical-stage therapies with known mechanisms of action that directly address these biologies, to dramatically improve patient outcomes. The company was founded in 2018 and was formerly known as Oncologie.

Sandieji

Series A in 2018
A Medical technology Company based in Nanjing,China.

Triastek

Series A in 2018
Triastek Co. Ltd., founded in 2015 and based in Nanjing, China, specializes in the manufacture of 3D printed pharmaceuticals and related medical equipment. The company offers a range of products, including blockbuster and orphan drugs, as well as complex drug delivery technologies. Triastek develops proprietary 3D printing technology that encompasses the entire process from drug formulation design to continuous production. Its Melt Extrusion Deposition (MED) technology is applicable to solid formulations, enabling innovative drug delivery and development solutions. The company has also filed patent applications for its technologies, emphasizing its commitment to advancing pharmaceutical manufacturing through 3D printing.

Yinglink

Series A in 2018
Provider of a imaging doctor service platform intended to improve the grading diagnosis of medical industry. The company's imaging doctor service platform provides a cloud-based internet service to helps radiologist to get better communication, improve diagnostic knowledge, enhance medical imaging skills and work remotely on Internet.

XPECT Vision

Series B in 2018
Founded in 2015, XpectVision Technology is a high-tech company committed to disruptive and innovative technology development. XpectVision has been trailblazing in the field of photon-counting X-ray imaging. Also the company is poised to be the leader of other futuristic imaging technology, including high-speed high-definition imaging chip.
Innovative Cellular Therapeutics Co.,Ltd. is a Shanghai-based biotechnology company engaged in research and development of cell therapy.

Eoitek

Series A in 2018
EOITEK develops and delivers big data analysis solutions. It offers AIOps, a self-developed intelligent operation and maintenance product that collects, processes, analyzes, and displays multi-dimensional full-scale operation and maintenance data, including fault events, performance indicators, various logs, operation and maintenance work orders, and configuration data. The company’s solutions are deployed onsite and are available as a subscription service model. It serves customer in various industries, including banking, insurance, securities, manufacturing, energy, and transportation. The company was founded in 2014 and is based in Shanghai, China.

TRON

Angel Round in 2018
TRON develops artificial intelligence technology to solve the most important third-level and fourth-level autopilot functions or equivalent features in the vehicle driving market. It focuses on automobile Engine control unit (ECU). The company was founded in 2017 and is based in Shanghai, China with additional office in California.

Aishen Medical

Series A in 2018
Aishen Medical (爱肾医疗) is a SaaS-based platform that offers kidney disease management services, particularly for patients with chronic kidney diseas. It focuses on the provision of popular science and chronic disease management services for patients with kidney disease.

Ishen365

Series A in 2018
Ishen365 develops and operates renal care service platform for healthcare sector. It provides chronic disease management solutions for patients with kidney disease. The company is based in Shanghai, China.

Dadao

Series B in 2018
Car sharing platform

Genus Tech

Series A in 2018
Genus Finance is a quantitative investment and technology trading platform. It is committed to providing safe, efficient and cost-effective algorithmic trading strategies and quantitative investment solutions for financial investment institutions such as public funds, private equity and securities firms.

Fourier Intelligence

Series A in 2018
Shanghai Fourier Intelligence Co. Ltd. specializes in the development of exoskeleton and rehabilitation robotics products aimed at enhancing mobility and therapeutic outcomes for users with movement impairments. Key products include the ExoMotus X2, an exoskeleton robot designed for walking assistance, and the ArmMotus M2, which aids in arm rehabilitation, focusing on shoulder and elbow joint movement. The WristMotus M1-W facilitates normal wrist movements, while CycleMotus provides an intuitive interface for patients to continue rehabilitation at home after clinical discharge. Additionally, the company is involved in various initiatives such as the Fourier Intelligence Group Therapy (FiGT), the Fourier Intelligent Rehabilitation Hub (FiRH), and the Fourier Exoskeleton & Robotics Open Platform System (EXOPS), which are aimed at advancing education and development in exoskeleton and robotics systems. Founded in 2015 and based in Shanghai, Fourier Intelligence combines technology and design to address the needs of individuals with disabilities and enhance their quality of life.

Polaris Biology

Seed Round in 2018
Shanghai Polaris Biology Co., Ltd. is a medical technology company focused on developing a cell diagnostic technology platform for tumors. Established in 2016 and based in Shanghai, China, the company utilizes artificial intelligence-based cell analysis models to examine dynamic changes in tumors at the cellular level. This innovative approach aims to enhance clinical tumor diagnosis and treatment by providing precise and accurate diagnostic tools for both patients and healthcare professionals. Polaris Biology is dedicated to advancing the understanding of individual tumor characteristics, thereby supporting more effective clinical decision-making in cancer care.

Polaris Technology Inc.

Seed Round in 2018
Polaris Technology i provides biomedical research institutes with cloud services of computational visualization and analysis specific to heterogeneous biomedical data. Our services are delivered to stakeholders through cloud-based deep learning models, cross-platform interactive data analysis systems, and crowd-sourcing data platforms.

Shanghai STEM Cloud

Series A in 2018
Provider of an internet platform designed for STEM (Science, Technology, Engineering and Math) education for students. The company offers core products in the form of online classes, tools, labs, and competitions, enabling educational institutions and individuals improve their STEM learning.

Weshine

Series B in 2017
WeShine is a Chinese platform specializing in the sharing of GIF images and video content. The service has reached over 800 million users across China, establishing a significant presence in the market with a reported market share of over 90% in the GIF search engine sector. WeShine offers a user-friendly interface that enables individuals to easily search for and share popular visual content, making it a prominent player in the digital media landscape.

Health Biotech

Angel Round in 2017
Beijing Health Biotech Co. Ltd. specializes in the development of diagnostic and therapeutic products aimed at the diagnosis, treatment, and monitoring of Alzheimer's disease. Founded in 2016 and based in Beijing, the company employs advanced mass spectrometry technology, specifically liquid chromatography-mass spectrometry, to facilitate early diagnosis and treatment. Its product offerings include a range of diagnostic tests for various conditions, including Alzheimer's disease, cardiovascular disease, and genetic metabolic disorders. In addition, the company provides therapeutic drug monitoring, neonatal genetic metabolic disease screening, and clinical testing services. Through its innovations, Health Biotech seeks to aid healthcare professionals in enhancing patient outcomes, particularly in improving cognitive abilities and delaying the onset of Alzheimer's disease.

Keyin Tech

Series A in 2017
Developer of surgery technology focusing on physical robotics and cloud technology platform. The company's main three systems are pre-surgery platform planning, surgery navigator, and surgery robotics, enabling surgeons to improve communications with patients and reducing surgery accidents.

Geek+

Series B in 2017
Geek+ has delivered the largest numbers of logistics robots among its peers in China. The company's customers include e-commerce platforms, third-party logistics providers, express delivery companies, offline retailers and manufacturers of apparels, pharmaceuticals, automobiles and electronics products. Geek+ has also established strategic partnerships with a number of key customers to co-develop customized AI and robotic solutions across different industries and applications.

Xiaodupi

Series C in 2017
Developer of a social media and gaming mobile application for girls younger than fourteen. The application gamifies career learning and social development, and offers incentives such as virtual fashion items for interacting on the platform.

Geek+

Series A in 2017
Geek+ has delivered the largest numbers of logistics robots among its peers in China. The company's customers include e-commerce platforms, third-party logistics providers, express delivery companies, offline retailers and manufacturers of apparels, pharmaceuticals, automobiles and electronics products. Geek+ has also established strategic partnerships with a number of key customers to co-develop customized AI and robotic solutions across different industries and applications.

Jianke

Series A in 2017
Guangdong Jianke Pharmaceutical Co., Ltd. owns and operates nine pharmacy stores in China. The company also operates an online pharmacy retail store. It offers hepatobiliary, dermatology, pediatric, and urology medicines; female medication; medicines for digestive system, nervous system, and respiratory system; nourishing health care products; medical instruments; and beauty care products. The company was founded in 2006 and is based in Dongguan, China.

Manhuadao

Series A in 2016
Provider of a mobile comic reading platform designed for non-commercial sharing and communication. The company's platform provides complete comic series from different genres in addition to original comic series from new comic artists, enabling avid comic lovers access to variety of comic selection while interacting with one another through the company's community forum.

OrigiMed

Angel Round in 2016
OrigiMed Inc. is a Shanghai-based company that specializes in research and clinical support services for cancer patients. The organization focuses on developing innovative technologies and clinical applications aimed at improving cancer care. By employing comprehensive and high-throughput methods, along with extensive bioinformatics analysis and clinical annotation, OrigiMed identifies cancer-specific molecular markers and genomic features. This information is utilized to guide targeted therapies and immunotherapy, contributing to the advancement of precision medicine for cancer treatment in China.

CreditX

Series A in 2016
CreditX is the advanced, independent provider of integrated financial risk management products.

Shebaotong

Series A in 2016
Shebaotong provides social security, provident fund, commercial insurance, salary services, labor cost optimization and other services.

Geek+

Series A in 2016
Geek+ has delivered the largest numbers of logistics robots among its peers in China. The company's customers include e-commerce platforms, third-party logistics providers, express delivery companies, offline retailers and manufacturers of apparels, pharmaceuticals, automobiles and electronics products. Geek+ has also established strategic partnerships with a number of key customers to co-develop customized AI and robotic solutions across different industries and applications.

Xiaodupi

Series B in 2015
Developer of a social media and gaming mobile application for girls younger than fourteen. The application gamifies career learning and social development, and offers incentives such as virtual fashion items for interacting on the platform.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.